National Health Investors (FRA:WX6) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WX6 National Health Investors Inc FRA:WX6
79 GF Score
Price €63.00
GF Value €72.82
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is National Health Investors Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of National Health Investors is: Moderate Risk: Sensitive, better choose undervalued stock.

National Health Investors  (FRA:WX6) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

National Health Investors Risk Assessment Related Terms

FRA:WX6 vs MPT, DHC, SBRA: Risk Assessment Comparison

For the REIT - Healthcare Facilities subindustry, National Health Investors's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

National Health Investors Risk Assessment vs REITs Industry

For the REITs industry and Real Estate sector, National Health Investors's Risk Assessment distribution charts can be found below:

* The bar in red indicates where National Health Investors's Risk Assessment falls into.


FRA:WX6
79GF Score
National Health Investors Inc FRA:WX6
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is National Health Investors (FRA:WX6) Overvalued in 2026?

Based on GuruFocus' analysis, National Health Investors stock appears to be undervalued. The current stock price of €63.00 is trading 13.5% below its estimated GF Value™ of €72.82. GuruFocus considers National Health Investors to be Modestly Undervalued.

Key valuation signals for FRA:WX6:

  • Risk Assessment:
  • GF Value™: €72.82 vs. price of €63.00 (13.5% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the FRA:WX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

National Health Investors Business Description

Industry Real EstateREITs
Other Exchanges NHI:USA
Address 222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
79GF Score

Get the complete analysis for FRA:WX6

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.00
Price
€72.82
GF Value